5,629 Shares in Maximus, Inc. (NYSE:MMS) Acquired by Cibc World Markets Corp

Cibc World Markets Corp acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,629 shares of the health services provider's stock, valued at approximately $420,000.

A number of other hedge funds also recently made changes to their positions in the business. Reinhart Partners LLC. raised its stake in Maximus by 43.5% in the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider's stock valued at $41,143,000 after acquiring an additional 167,019 shares during the period. Sio Capital Management LLC bought a new position in shares of Maximus in the third quarter valued at about $14,453,000. Ruffer LLP bought a new position in shares of Maximus in the fourth quarter valued at about $10,266,000. Barclays PLC lifted its stake in shares of Maximus by 285.1% during the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock worth $15,927,000 after buying an additional 126,573 shares during the last quarter. Finally, Empowered Funds LLC acquired a new position in Maximus in the 4th quarter valued at about $8,139,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a research note on Thursday, January 2nd.

Remove Ads

Maximus Stock Performance

Shares of MMS stock traded up $1.03 on Thursday, hitting $68.06. The company's stock had a trading volume of 357,414 shares, compared to its average volume of 491,808. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a market capitalization of $3.85 billion, a PE ratio of 14.64 and a beta of 0.71. The stock's 50 day moving average is $70.42 and its 200-day moving average is $78.09. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. The ex-dividend date of this dividend was Friday, February 14th. Maximus's dividend payout ratio (DPR) is currently 25.81%.

Insider Buying and Selling

In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.